Simplify Logo

Full-Time

Associate Director

Commercial Analytics & Forecasting

Confirmed live in the last 24 hours

Axsome Therapeutics Inc

Axsome Therapeutics Inc

501-1,000 employees

Develops therapies for CNS disorders

Hardware
Biotechnology

Compensation Overview

$150k - $190kAnnually

+ Bonus + Equity

Senior, Expert

New York, NY, USA

Category
Bioinformatics
Computational Biology
Genomics
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Bachelor's degree preferably Engineering, Math, Physics, Statistics & Operations Research
  • 7+ years pharmaceutical or biotechnology experience in Commercial Analytics/Forecasting or Sales Analytics roles
  • Advanced degree, including MBA, or Masters/PhD in a quantitative field such as Engineering, Math, Physics, Statistics & Operations Research preferred
  • Previous product launch experience
  • Ability to work on site Monday, Tuesday & Thursday.*We are unable to consider candidates who are looking for fully remote roles.*
Responsibilities
  • Generate analytics-based insights by leveraging various pharmaceutical data sources (longitudinal patient data, HCP prescribing data, payor data, national and subnational data on key metrics like patients, prescriptions, sales etc.)
  • Collaborate closely with other commercial analytics and insights team members to ensure insights from secondary data analytics are appropriately integrated with insights from other sources
  • Update and maintain brand forecast models to reflect the latest competitive intelligence landscape, customer research and insights from claims data
  • Create short term and long term forecasts and effectively communicate them to various stakeholders at Axsome (Commercial, Finance, Supply Chain etc.)
  • Easily translate commercial analytics results to help deepen our understanding of market opportunities and customer behaviors
  • Turn unstructured business issues/requests into appropriate analytical action plans and projects that result in high quality, meaningful and actionable deliverables
  • Provide accurate and in-depth analyses to commercial leadership teams and serves as an integral part of the commercial team
  • Support initiatives by leveraging expertise in drawing insights from large data sets
  • Manage multiple complex pieces of data analysis and translating that analysis into actionable commercial insights
  • Identify, evaluate, and manage relationships with best-in-class analytics vendors
Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain to help regulate mood. This drug has shown positive results in clinical trials and has received FDA Breakthrough Therapy Designation, which speeds up its development process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and clinical trials. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York City, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

92%

1 year growth

92%

2 year growth

92%
Simplify Jobs

Simplify's Take

What believers are saying

  • The launch of Auvelity and the promising results of AXS-12 in Phase 3 trials indicate strong potential for revenue growth and market impact.
  • Axsome's strategic expansion of its sales force to support Auvelity's launch demonstrates its commitment to commercial success.
  • The appointment of experienced leaders like Dr. Sue Mahony to the board enhances Axsome's strategic direction and governance.

What critics are saying

  • The biopharmaceutical sector's inherent risks, including regulatory hurdles and clinical trial failures, could impact Axsome's progress.
  • High competition in the CNS disorder treatment market may challenge Axsome's ability to capture significant market share.

What makes Axsome Therapeutics Inc unique

  • Axsome Therapeutics focuses on CNS disorders with a strong emphasis on unmet medical needs, setting it apart from broader biopharmaceutical companies.
  • The FDA Breakthrough Therapy Designation for AXS-05 highlights its innovative approach and potential for rapid market entry.
  • Axsome's diversified pipeline, including treatments for MDD, TRD, Alzheimer's agitation, and narcolepsy, showcases its comprehensive strategy in CNS therapeutics.